Skip to main content
Krka logo

Krka — Investor Relations & Filings

Ticker · KRKG ISIN · SI0031102120 LEI · 549300H9RLRTRTLRUZ73 LJSE Manufacturing
Open in API
Filings indexed 1,889 across all filing types
Latest filing 2017-09-25 Director's Dealing
Country SI Slovenia
Listing LJSE KRKG

About Krka

https://www.krka.biz/en/

Krka is an international generic pharmaceutical company engaged in the development, production, marketing, and sales of human and animal health products. The company's core business is focused on generic prescription pharmaceuticals, which it markets under its own brands. Its product portfolio is complemented by a range of non-prescription products and a comprehensive line of animal health products. With a history spanning over 70 years, Krka is committed to providing high-quality, effective, and safe products to a global market, aiming to contribute to a better quality of life.

Recent filings

Filing Released Lang Actions
Notification of transactions by persons discharging managerial responsibilities
Director's Dealing Classification · 100% confidence The document is titled 'Notification of transactions by persons discharging managerial responsibilities' and details the sale of shares by the Sales Director (a person discharging managerial responsibilities). This directly corresponds to the definition of Director's Dealing (insider trades). The appropriate code is DIRS.
2017-09-25 English
Razkritje poslov osebe, ki opravlja poslovodne naloge
Director's Dealing Classification · 99% confidence The document is titled 'Razkritje poslov osebe, ki opravlja poslovodne naloge' (Disclosure of transactions by a person discharging managerial responsibilities) and explicitly mentions that the Director of Sales, Damjan Možina, sold 800 shares of the company on September 19, 2017. This directly relates to insider trading or transactions by management/directors. This aligns perfectly with the definition for Director's Dealing (DIRS). The document is short and contains the specific transaction details, not just an announcement of a report.
2017-09-25 Slovene
Acquisition of treasury shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its category as 'Acquisition or disposal of the issuer's own shares' and details the 'Acquisition of treasury shares' (buy-back programme) over a specific period (15 September 2017 to 21 September 2017). This directly matches the definition for 'Transaction in Own Shares' (Code: POS), which covers company buying back or selling its own shares (share repurchase/issuance). The document is a specific regulatory disclosure about share repurchases, not a general announcement of a report (RPA/RNS).
2017-09-25 English
Pridobivanje lastnih delnic
Transaction in Own Shares Classification · 100% confidence The document text is in Slovenian and its category is explicitly stated as 'Pridobitev in odsvojitev izdajateljevih lastnih delnic' (Acquisition and disposal of the issuer's own shares). The content details the daily transactions (number of shares bought and total value) conducted by KRKA, d. d., Novo mesto, regarding its share repurchase program between September 15 and September 21, 2017. This directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers share repurchases. The document is a specific report detailing the execution of a share buyback program, not just an announcement of a report (RPA) or a general regulatory filing (RNS).
2017-09-25 Slovene
Project in China
Regulatory Filings Classification · 90% confidence The document is very short (590 characters) and announces a specific business development: establishing a joint venture in China, referencing a prior notice. This is a material event disclosure, often classified as 'Inside Information' or a general regulatory announcement. It does not fit the specific definitions for 10-K, ER, IR, DIV, or DIRS. Since it is a specific business update that doesn't fit the other specialized categories (like M&A, Financing, or Management changes), and it is a direct disclosure of material information, the most appropriate general category for non-standard regulatory disclosures is 'Regulatory Filings' (RNS). It is not an announcement *about* a report, but the report itself (a brief update).
2017-09-22 English
Projekt na Kitajskem
Regulatory Filings Classification · 95% confidence The document is a short announcement (981 characters) published on SEOnet, dated September 21, 2017. It references Slovenian regulatory rules ('Pravil Ljubljanske borze', 'Zakon o trgu finančnih instrumentov', 'Uredbe (EU) št. 596/2014') and discloses information about establishing a joint venture in China. This type of mandatory disclosure, which is not a full financial report (like 10-K or IR) but rather a specific corporate action update, fits best under the general 'Regulatory Filings' category (RNS) as it is a mandatory, non-standard announcement. It is too specific for RNS if a better fit exists, but it doesn't match ER, CT, DIRS, DIV, or CAP. Since it is a mandatory disclosure of a strategic move (Project in China), and it is not a report publication announcement (RPA) itself, RNS is the most appropriate fallback for a general regulatory disclosure that doesn't fit the other specific categories like M&A (TAR) or Financing (CAP). Given the context of mandatory disclosure under EU/Ljubljana Stock Exchange rules, RNS is the best fit.
2017-09-22 Slovene

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.